Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6838840 | 0.97 | — | — | |
| SCHEMBL11363933 | 0.75 | LMNA (0.36) | — | |
| SCHEMBL9484496 | 0.69 | GAA (0.43) | — | |
| SCHEMBL11202064 | 0.68 | TSHR (0.32) | CYP2C19 | |
| SCHEMBL8783419 | 0.65 | — | — | |
| SCHEMBL11530873 | 0.62 | LMNA (0.32) | — | |
| SCHEMBL15919215 | 0.61 | — | — | |
| SCHEMBL31347365 | 0.61 | — | — | |
| SCHEMBL11354593 | 0.59 | — | — | |
| SCHEMBL7317737 | 0.58 | CYP2C19 (0.50) | CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107805225-B | Preparation method of 5-mercapto tetrazole acetic acid and sodium salt thereof | 九江中星医药化工有限公司 | 2020-06-26 | — | — | CN | claimed |
| EP-1711575-A2 | DEICER COMPOSITIONS INCLUDING CORROSION INHIBITORS | Cargill, Incorporated (US) | 2006-10-18 | — | — | EP | claimed |
| WO-2005071036-A2 | DEICER COMPOSITIONS INCLUDING CORROSION INHIBITORS | CARGILL, INCORPORATED (US) | 2005-08-04 | — | — | WO | claimed |
| US-4374994-A | Process for preparation of 5-mercaptotetrazolyl-1-acetic acid | BRISTOL-MYERS COMPANY (US) | 1983-02-22 | — | — | US | claimed |
| US-4271296-A | CEPHALOSPORINS AND DERIVATIVES | SHIONOGI & CO., LTD. (JP) | 1981-06-02 | — | — | US | claimed |
| JP-59031759-A | — | — | None | — | — | JP | disclosed |
| US-20250092171-A1 | HIGH-PURITY 4-(2-BROMOETHYL)BENZENESULFONIC ACID, HIGH-PURITY STYRENESULFONIC ACID COMPOUND DERIVED THEREFROM, AND POLYMER THEREOF, AND METHODS FOR PRODUCING SAME | TOSOH FINECHEM CORPORATION (JP) | 2025-03-20 | — | — | US | disclosed |
| CN-118843614-A | High-purity 4- (2-bromoethyl) benzenesulfonic acid, high-purity styrenesulfonic acid derived therefrom, polymer thereof, and process for producing these | 东曹精细化工株式会社 | 2024-10-25 | — | — | CN | disclosed |
| CN-113597439-B | Amphoteric polyelectrolytes of novel polystyrene substrates with highest critical co-solvent temperature and use thereof | 东曹精细化工株式会社 | 2024-08-02 | — | — | CN | disclosed |
| CN-110997631-B | High purity amphiphilic arylsulfonic acid amine salt vinyl monomers and (co) polymers thereof | 东曹精细化工株式会社 | 2022-07-15 | — | — | CN | disclosed |
| CN-113956270-A | Preparation method of main degradation product of ceforanide | 成都大学 | 2022-01-21 | — | — | CN | disclosed |
| CN-113597439-A | Novel polystyrene-based amphoteric polyelectrolytes having a maximum critical eutectic temperature and uses thereof | 东曹精细化工株式会社 | 2021-11-02 | — | — | CN | disclosed |
| EP-0076463-A2 | Beta-lactam compound and a pharmaceutical composition containing the same | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1983-04-13 | — | — | EP | disclosed |
| US-4374994-A | Process for preparation of 5-mercaptotetrazolyl-1-acetic acid | BRISTOL-MYERS COMPANY (US) | 1983-02-22 | — | — | US | disclosed |
| US-4374994-A | Process for preparation of 5-mercaptotetrazolyl-1-acetic acid | BRISTOL-MYERS COMPANY (US) | 1983-02-22 | — | — | US | disclosed |
| US-4374994-A | Process for preparation of 5-mercaptotetrazolyl-1-acetic acid | BRISTOL-MYERS COMPANY (US) | 1983-02-22 | — | — | US | disclosed |
| US-4271296-A | CEPHALOSPORINS AND DERIVATIVES | SHIONOGI & CO., LTD. (JP) | 1981-06-02 | — | — | US | disclosed |
| US-4271295-A | HALOGENATION STEP | SHIONOGI & CO., LTD. (JP) | 1981-06-02 | — | — | US | disclosed |
| US-4220766-A | FROM PENICILLINS | SHIONOGI & CO., LTD. (JP) | 1980-09-02 | — | — | US | disclosed |
| US-4201781-A | BACTERICIDES | DAINIPPON PHARMACEUTICAL CO., LTD. (JP) | 1980-05-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250092171-A1 | HIGH-PURITY 4-(2-BROMOETHYL)BENZENESULFONIC ACID, HIGH-PURITY STYRENESULFONIC ACID COMPOUND DERIVED THEREFROM, AND POLYMER THEREOF, AND METHODS FOR PRODUCING SAME | BRPF1, WEE2, WEE1 | CYP2C19 3356/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.